[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$feeG1qdubhFF16-wuTAP9zQ_bI5dIKLI4vKr6SH01qDU":8,"$fwpWTTcd-g9ybRVU7u-g52-UdFr_xwcQoFzc_XEc7lxc":55,"$fcBO4BelbhrbINr9GB0HJTBoWm1Ckk78Ntf34kYvttVw":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},58906,867451,[],"https://ystcdn.venuertc.com/medical/ystApp/t0US13DNdGYbbVXINAX1q5n2vRwR8fnc.png","霍文捷","山西省人民医院","肿瘤科","主治医师",109,0,"HER-2靶向及辅助药物在IIB期乳腺导管癌化疗中的安全用药指南","","https://ystcdn.venuertc.com/venue/AI/330283c0-7a39-40b9-b024-3fd99fae1844.jpg","\u003Cdiv class=\"drugguide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drugguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">HER-2靶向及辅助药物在IIB期乳腺导管癌化疗中的安全用药指南\u003C/h2>\n  \u003Cdiv class=\"drugguide-intro\">\n    \u003Cp>\n      在乳腺肿瘤化疗方案中，HER-2阳性患者常需联合多种药物，如紫杉醇类、铂类，还可能辅以质子泵抑制剂和保肝类药物。每种药品的用法细节都与疗效和安全性密切相关。本文将为大家详细讲解7大用药关键点，包括剂型、服用方法、不良反应、相互作用、特殊人群注意事项等，帮助大家更安心地用药与规避风险。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 第一部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f6fafe 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1️⃣ 紫杉醇类药物的安全用药要点\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">常用剂型与作用机制🧬\u003C/h3>\n      \u003Cp>\n        紫杉醇类（Taxanes，如Paclitaxel、Docetaxel）多为静脉注射剂型。它通过抑制癌细胞分裂，对生长迅速的细胞起抑制作用。在治疗HER-2阳性患者时，常被纳入多药联合化疗中。\n      \u003C/p>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">正确用法与注意细节\u003C/h3>\n      \u003Cul>\n        \u003Cli>需严格遵医嘱在医院由专业医护静脉点滴。\u003C/li>\n        \u003Cli>滴注前后需监测生命体征，使用微量泵安全控制速度。\u003C/li>\n        \u003Cli>服药日前后避免服用有影响肝酶的药物（详见后文相互作用部分）。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">常见不良反应及应对\u003C/h3>\n      \u003Cul>\n        \u003Cli>脱发、恶心和注射部位疼痛常见，脱发可为可逆。\u003C/li>\n        \u003Cli>听从医师指导如出现肢体麻木及时报告。\u003C/li>\n        \u003Cli>过敏风险较低但需警惕呼吸困难、荨麻疹等异常，第一时间就医。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">特殊人群用药\u003C/h3>\n      \u003Cul>\n        \u003Cli>肝功能不全患者需减量或延后；肾功能不全一般无需调整。\u003C/li>\n        \u003Cli>孕妇、哺乳期禁用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第二部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f4f1fa 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2️⃣ 铂类药物的应用和规避风险\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">剂型特点与药理机制💉\u003C/h3>\n      \u003Cp>\n        铂类（如顺铂Cisplatin、卡铂Carboplatin）为静脉注射制剂，通过干扰DNA复制，抑制肿瘤细胞分裂。常见于HER-2靶向治疗的联合化疗方案。\n      \u003C/p>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药流程与特殊步骤\u003C/h3>\n      \u003Cul>\n        \u003Cli>严格在医院静脉点滴给药，由医护人员根据方案调控滴速和总剂量。\u003C/li>\n        \u003Cli>注射前充分补水，有助预防肾毒性。\u003C/li>\n        \u003Cli>用药期间需频繁监测肝、肾功能和电解质。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要不良反应及防范措施\u003C/h3>\n      \u003Cul>\n        \u003Cli>肾损害、听力下降、恶心、呕吐需严密监控。出现视力、尿量变化，需及时联系医师。\u003C/li>\n        \u003Cli>部分患者出现白细胞减少，应定期查血象。\u003C/li>\n        \u003Cli>使用中如有耳鸣、听力下降，立刻停止药物。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">特殊人群注意🔍\u003C/h3>\n      \u003Cul>\n        \u003Cli>肾功能不佳者慎用，孕妇、哺乳期禁用。\u003C/li>\n        \u003Cli>老人需密切观察肾脏和骨髓抑制等不良反应。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第三部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #fefcf5 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3️⃣ 靶向HER-2药物的用药细节（以曲妥珠单抗为例）\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要剂型和作用机制\u003C/h3>\n      \u003Cp>\n        曲妥珠单抗（Trastuzumab）大多为静脉注射，也有皮下注射形式。它能精准靶向HER-2受体，阻断肿瘤细胞信号通路，控制HER-2阳性肿瘤细胞的增殖。\n      \u003C/p>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">给药注意事项\u003C/h3>\n      \u003Cul>\n        \u003Cli>初次给药常以较低速度缓慢滴注，减少过敏风险。\u003C/li>\n        \u003Cli>每次用药前需检测心功能（尤其关注左心室射血分数）。\u003C/li>\n        \u003Cli>若联合紫杉醇类用药，需根据化疗方案合理安排用药先后。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">常见不良反应及处理方法\u003C/h3>\n      \u003Cul>\n        \u003Cli>注射相关反应（如发热、寒战），多在首剂中发生，给予对症处理。\u003C/li>\n        \u003Cli>长期使用罕见心脏毒性，定期复查心脏功能。\u003C/li>\n        \u003Cli>极少数人会出现急性过敏反应（呼吸困难、皮疹），须立即停药。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药相互作用须知\u003C/h3>\n      \u003Cul>\n        \u003Cli>曲妥珠单抗与蒽环类药物同时使用，心脏毒性风险提升，应避免同日给药。\u003C/li>\n        \u003Cli>与其它心脏疾病治疗药同时服用时需提前与医生说明。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第四部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #fafdfe 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4️⃣ 辅助药物：质子泵抑制剂与保肝类药物的安全守则 🍵\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">质子泵抑制剂（如奥美拉唑、艾司奥美拉唑）\u003C/h3>\n      \u003Cul>\n        \u003Cli>多为口服片剂，餐前30~60分钟服下。\u003C/li>\n        \u003Cli>用温水吞服，不可嚼碎或掰开肠溶片。\u003C/li>\n        \u003Cli>长期合用需定期电解质、肠道菌群监测。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">保肝药常见类型\u003C/h3>\n      \u003Cul>\n        \u003Cli>常用制剂有多烯磷脂酰胆碱、还原型谷胱甘肽，多为静脉滴注。\u003C/li>\n        \u003Cli>需与主药错时使用，以减少药物间干扰。\u003C/li>\n        \u003Cli>对输液过敏史患者需提前落实药物安全性评估。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">与主药联合时的注意点\u003C/h3>\n      \u003Cul>\n        \u003Cli>质子泵抑制剂能降低某些药物（如抗真菌药氟康唑）的吸收。\u003C/li>\n        \u003Cli>保肝类药物不宜与高钙液等混合滴注。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第五部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #edfcf7 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5️⃣ 用药过程中如何避免相互作用？\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">重点警惕的药物组合🚫\u003C/h3>\n      \u003Cul>\n        \u003Cli>紫杉醇与酮康唑、伊曲康唑等CYP3A4抑制剂同用时，易引发药物毒性，务必提前报告服药史。\u003C/li>\n        \u003Cli>顺铂与氨基糖苷类抗生素联用，增加肾损伤风险。\u003C/li>\n        \u003Cli>曲妥珠单抗与蒽环类心脏毒性药不应同日用药。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">服药先后顺序和间隔\u003C/h3>\n      \u003Cul>\n        \u003Cli>静脉药物通常分不同时段分别滴注，切勿混合。\u003C/li>\n        \u003Cli>口服制剂应与主药用药分开，最少间隔1小时。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">生活中常见的误区\u003C/h3>\n      \u003Cul>\n        \u003Cli>误以为所有维生素、营养素和主药无冲突。应提前咨询医师。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第六部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #fef7fa 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6️⃣ 不良反应的识别与处理方法\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">最常见的不良反应表现及应对 👍\u003C/h3>\n      \u003Cul>\n        \u003Cli>紫杉醇常见脱发、周围神经麻痹。\u003C/li>\n        \u003Cli>铂类可能有恶心、肾功能损害。\u003C/li>\n        \u003Cli>曲妥珠单抗罕见心脏不适，需注意胸闷、乏力等变化。\u003C/li>\n        \u003Cli>质子泵抑制剂长期使用或导致低镁低钙等电解质异常，偶见腹泻。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">处理建议\u003C/h3>\n      \u003Cul>\n        \u003Cli>出现异常反应勿自行停药，及时联系主管医生。\u003C/li>\n        \u003Cli>皮疹、腹泻等轻度不适者，判断后可考虑调整辅助用药。\u003C/li>\n        \u003Cli>心脏、听力或神经系统反应明显时，需专科随访或药物更换。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">典型用药案例分享\u003C/h3>\n      \u003Cul>\n        \u003Cli>有位患者在紫杉醇治疗期间出现轻度手脚麻木，经药师评估后调整辅药配比，症状缓解。\u003C/li>\n        \u003Cli>临床上曾有铂类用药后出现听力下降，立即停药后并进行相关处理，避免了不可逆损伤。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 第七部分 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f8fbfa 80%, transparent 100%);\">\n    \u003Ch2 class=\"drugguide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7️⃣ 储存条件、有效期与用药细节⚖️\u003C/h2>\n    \u003Cdiv class=\"drugguide-section-content\">\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">药品储存的标准要求\u003C/h3>\n      \u003Cul>\n        \u003Cli>紫杉醇、质子泵抑制剂和曲妥珠单抗需在干燥避光、25℃以下保存。\u003C/li>\n        \u003Cli>静脉制剂调配后尽快用完，避免放置超时。\u003C/li>\n        \u003Cli>如有针剂需冷藏（2-8℃），勿冷冻。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">过期、变质药品如何安全处理\u003C/h3>\n      \u003Cul>\n        \u003Cli>严禁自行丢弃、焚烧，应送指定药品回收点处置。\u003C/li>\n        \u003Cli>发现药瓶破损、液体浑浊、变色，不可再用。\u003C/li>\n      \u003C/ul>\n      \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药过程中遗漏或过量应对\u003C/h3>\n      \u003Cul>\n        \u003Cli>静脉输液严禁自行调整剂量，出现问题立刻报告。\u003C/li>\n        \u003Cli>如漏服口服药，发现时可及时补服，下次仍按原计划。\u003C/li>\n        \u003Cli>过量服用，尤其静脉制剂，需立即就医。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语 -->\n  \u003Cdiv class=\"drugguide-summary\">\n    \u003Cp>\n      总结来看，乳腺肿瘤治疗用药流程复杂，各类化疗、靶向及辅助药品均有专属的用法、禁忌与注意点。有条不紊地遵医嘱服用、严格把控用药细节、密切观察副作用，不仅能提升治疗效果，更防范了不少风险。最关键的是，遇到疑问要及时咨询专业医师/药师，不要自行调整用药。每一步都关系到药品的疗效和安全。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 文献引用 -->\n  \u003Cdiv class=\"drugguide-ref-area\">\n    \u003Ch3 class=\"drugguide-h3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Cul class=\"drugguide-ref-ul\">\n      \u003Cli>Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., et al. (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. \u003Cem>New England Journal of Medicine, 353\u003C/em>(16), 1659–1672. https://doi.org/10.1056/NEJMoa052306 （参见靶向药物部分）\u003C/li>\n      \u003Cli>Martin, M., Pienkowski, T., Mackey, J., et al. (2005). Adjuvant docetaxel for node-positive breast cancer. \u003Cem>New England Journal of Medicine, 352\u003C/em>(22), 2302–2313. https://doi.org/10.1056/NEJMoa043681 （见紫杉醇药理和不良反应）\u003C/li>\n      \u003Cli>O’Shaughnessy, J. A., et al. (2002). Anticancer Therapy: Platinum Agents in Breast Cancer. \u003Cem>Seminars in Oncology, 29\u003C/em>(6 Suppl 19), 37–49.（铂类药物部分）\u003C/li>\n      \u003Cli>Dürr, U. H., et al. (2006). Proton pump inhibitors–side effects and drug interactions. \u003Cem>Current Gastroenterology Reports, 8\u003C/em>(5), 375-381. （辅助药物板块）\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drugguide-container {\n  max-width: 800px;\n  margin: 36px auto 60px;\n  background: #fcfdff;\n  border-radius: 20px;\n  box-shadow: 0 8px 32px rgba(22,64,108,.12);\n  padding: 38px 32px 42px 32px;\n  font-family: 'Segoe UI', 'PingFang SC', 'Hiragino Sans GB', 'Arial', sans-serif;\n  font-size: 18px;\n  color: #205080;\n  line-height: 1.8;\n}\n\n.drugguide-title {\n  text-align: center;\n  font-size: 2.3em;\n  font-weight: 700;\n  padding-bottom: 16px;\n  color: #1b3353;\n  margin-bottom: 8px;\n  border-bottom: 2.5px solid #e7eef5;\n  letter-spacing: 1px;\n}\n\n.drugguide-intro {\n  padding: 8px 10px 15px 10px;\n  font-size: 1.1em;\n  background: linear-gradient(90deg,#e9f6fc 60%, #f9f9ff 100%);\n  border-radius: 8px 8px 8px 8px;\n  margin-bottom: 1.8em;\n  color: #31557f;\n}\n\n.drugguide-section {\n  margin: 28px 0 40px 0;\n  padding: 30px 24px 28px 24px;\n  border-radius: 18px;\n  background-repeat: no-repeat;\n  background-size: cover;\n  box-shadow: 0 1.5px 8px rgba(22,64,108,.04);\n  border: 1.5px solid #e7eafc;\n}\n\n.drugguide-h2 {\n  font-size: 1.5em;\n  font-weight: 700;\n  color: #245d82;\n  margin-bottom: 13px;\n  letter-spacing: 0.8px;\n  position: relative;\n}\n\n.drugguide-section-content {\n  font-size: 1.07em;\n  padding-top: 4px;\n  color: #244f53;\n}\n\n.drugguide-h3 {\n  font-size: 1.14em;\n  margin: 20px 0 8px 0;\n  font-weight: 600;\n  color: #366c85;\n  letter-spacing: 0.5px;\n}\n\n.drugguide-section-content ul {\n  margin-left: 1.1em;\n  margin-bottom: 12px;\n}\n\n.drugguide-section-content li {\n  margin-bottom: 10px;\n  line-height: 1.65;\n  color: #244f53;\n}\n\n.drugguide-summary {\n  margin: 40px 0 20px 0;\n  font-size: 1.09em;\n  padding: 18px 26px 18px 18px;\n  background: linear-gradient(90deg, #e4f5fa 60%, #fbf7fb);\n  border-radius: 12px;\n  color: #245d82;\n  border-left: 4.5px solid #99d7ea;\n}\n\n.drugguide-ref-area {\n  margin: 36px 0 0 0;\n  background: #f8fafb;\n  border-radius: 12px;\n  padding: 16px 18px 15px 18px;\n  color: #2e4d64;\n  box-shadow: 0 1px 6px rgb(86 172 204 / 5%);\n  font-size: 1em;\n  border: 1.5px solid #e7eafc;\n}\n\n.drugguide-ref-ul {\n  margin-left: 22px;\n  font-size: 0.98em;\n}\n\n@media (max-width: 600px) {\n  .drugguide-container { padding: 14px 1.7vw 18px 1.7vw; font-size: 15.7px;}\n  .drugguide-title { font-size: 1.48em;}\n  .drugguide-section { padding: 14px 2vw 15px 2vw; }\n  .drugguide-summary { padding: 10px 4vw 12px 3vw; font-size: 1em;}\n}\n\u003C/style>\n","\u003Cdiv class=\"drugguide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drugguide-title\" style=\"color: rg",513,"2025-08-14 10:40:19","HER-2, 乳腺癌化疗, 紫杉醇, 铂类药物, 靶向治疗, 不良反应, 安全用药, 辅助药物","本文提供了关于HER-2阳性乳腺癌患者化疗中紫杉醇、铂类及靶向药物的安全使用指南，帮助患者掌握用药要点和避风险。医师推荐，每步用药都至关重要！","2025-08-21 22:36:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]